S.Korea will check for human rights violations for workers detained in US-March 2024-www.financetom.com

S.Korea will check for human rights violations for workers detained in US

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

S.Korea will check for human rights violations for workers detained in US

Sep 14, 2025 6:46 PM

SEOUL, Sept 15 (Reuters) - South Korea will check with

companies whether there were any human rights violations for

Korean workers that were detained in the U.S., the presidential

spokesperson said on Monday.

More than 300 South Korean workers made a dramatic return

home on Friday after about a week of detention in a U.S.

immigration detention facility.

Previous page： Comcast tops revenue expectations on Olympics ad boost, blockbuster releases Next page： BRIEF-Aerovate Therapeutics And Jade Biosciences Announce Merger Agreement

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Comcast tops revenue expectations on Olympics ad boost, blockbuster releases

Nov 3, 2024

(Reuters) -Comcast ( CMCSA ) beat third-quarter revenue estimates on Thursday, driven by strong box office performance for its studio, higher ad sales during the 2024 Paris Olympics and a smaller-than-expected decline in broadband subscribers. Shares of the company rose 4.2% in premarket trading. The company's media business saw a $1.9 billion revenue boost from the Paris Games, its highest-ever...

BRIEF-Aerovate Therapeutics And Jade Biosciences Announce Merger Agreement

Nov 3, 2024

Oct 31 (Reuters) - Aerovate Therapeutics Inc ( AVTE ): * AEROVATE THERAPEUTICS AND JADE BIOSCIENCES ANNOUNCE MERGER AGREEMENT * AEROVATE THERAPEUTICS INC ( AVTE ) - JADE SECURES $300 MILLION IN PRIVATE INVESTMENT * AEROVATE THERAPEUTICS INC ( AVTE ) - STOCKHOLDERS TO OWN 1.6% OF COMBINED COMPANY * AEROVATE THERAPEUTICS INC ( AVTE ) - TOM FROHLICH TO...

Entergy's Q3 Adjusted Earnings Decline; Raises Lower End of Fiscal 2024 Adjusted EPS Guidance

Nov 3, 2024

07:11 AM EDT, 10/31/2024 (MT Newswires) -- Entergy ( ETR ) reported Q3 adjusted earnings Thursday of $2.99 per share, down from $3.27 a year earlier. Analysts polled by Capital IQ expected $2.99. The company said it now expects fiscal 2024 adjusted EPS of $7.15 to $7.35. That compares with its previous forecast of $7.05 to $7.35. Analysts polled by...

Regeneron Pharmaceuticals' Q3 Adjusted Net Income, Revenue Rises

Nov 3, 2024

07:13 AM EDT, 10/31/2024 (MT Newswires) -- Regeneron Pharmaceuticals ( REGN ) reported Q3 non-GAAP net income Thursday of $12.46 per diluted share, up from $11.59 a year earlier. Analysts polled by Capital IQ expected $11.71. Total revenue for the quarter ended Sept. 30 was $3.72 billion, up from $3.36 billion a year earlier. Analysts surveyed by Capital IQ expected...